Return
Company Page
SpectaCell
SpectaCell is a Belgian life sciences company developing a next-generation, label-free single-cell analysis platform for drug development and manufacturing. Spun out of imec, VIB and Ghent University, its proprietary technology combines chip-based digital imaging and data analysis to measure how treatments affect individual cells in real time, delivering results within hours instead of days. The platform targets immunotherapies including cell therapies and T-cell engagers, serving biopharma and biotech companies from early research through to routine manufacturing and quality control.
Company Founded in 2026
Healthtech & Biotech